Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge

Journal of Virology

Volumn 76, Issue 5, 2002, Pages 2100-2112

  Ye, Ming ^a   Morello, Christopher S ^a   Spector, Deborah H ^a  

^a SECTION OF MOLECULAR BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; M84 ANTIGEN; PP89 ANTIGEN; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; IMMUNIZATION; IMMUNOASSAY; INFECTION PREVENTION; LYMPHOCYTE COUNT; MOUSE; MURINE CYTOMEGALOVIRUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3 CELLS; ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS VACCINES; DNA, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; IMMEDIATE-EARLY PROTEINS; IMMUNIZATION; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; PHOSPHOPROTEINS; PLASMIDS; UBIQUITIN; VIRAL MATRIX PROTEINS;

EID: 0036168327     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.76.5.2100-2112.2002     Document Type: Article

References (36)

1. + T cells
2. Cytomegalovirus
3. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): Use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response
4. Identification, analysis, and evolutionary relationship of the putative murine cytomegalovirus homologues of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins
5. DNA vaccination against tuberculosis: Expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity
6. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope
7. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status
8. Protective cellular immunity: Cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization
9. Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens
10. DNA immunization confers protection against murine cytomegalovirus infection
11. DNA vaccines: Immunology, application, and optimization
12. + T-cell responses induced by DNA immunization
13. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization
14. Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65)
15. Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates
16. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells
17. d-restricted antigenic peptide encoded by murine cytomegalovirus early gene M84
18. + T lymphocytes
19. A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection
20. + T lymphocytes
21. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface
22. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity
23. In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83)
24. Suppression of murine cytomegalovirus replication with a DNA vaccine encoding the MCMV early nonstructural protein M84 (a homolog of human cytomegalovirus pp65)
25. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
26. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation
27. In vivo protection studies with MCMV glycoproteins gB and gH expressed by vaccinia virus
28. Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus
29. Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection
30. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes
31. DNA immunization with minigenes: Low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination
32. + T-cell populations with differing cytolytic activities
33. DNA immunization: Ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction
34. + T cells
35. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence
36. Prevention of transfusion-acquired cytomegalovirus infection in newborn infants